<?xml version="1.0" encoding="UTF-8" ?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
	<head>
		<meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
		<title>Science Gurus - Board Members</title>
		<link rel = "stylesheet" media = "screen" href = "css/bootstrap.min.css" />
		<link rel = "stylesheet" media = "screen" href = "css/style.css" />
		<link rel="stylesheet" href="css/font-awesome.min.css">
		<link rel="stylesheet" href="css/cmenus.css">
		<link rel="stylesheet" href="css/jquery-ui.css">
 
		<script src="js/jquery-ui.js"></script>
		<script src="js/jquery.min.js"></script>
		<script src="js/bootstrap.min.js"></script>
		<script src="js/sciencegurus.js"></script>
				
		<script>
			$(document).ready(function(){
				$("#header").load("header.htm");
				$("#right").load("rightColumn.htm");
				$("#footer").load("footer.htm");
			});
		</script>
	</head>
	<body>
		<div id="wrapper">
			<div id="header"></div>		
			
			<div id = "content">
				<div class="row">
					<div class="col-md-8">
						<div class="row">
							<div class="col-md-12">
								<div class="panel panel-primary">
									<div class="panel-heading"><b>Board Members</b></div>
									<div class="panel-body">
										<table>
											<tr><td><b>Robert Figari</b></td><td><a href="https://www.linkedin.com/in/robert-m-figari-m-a-17290a/"><img src="resources/linkedIn_PNG38.png" width="40" height="40"></a></td></tr>
											<tr><td>Robert Figari holds a MA in psychology. He has been a consultant in leadership development, communications
												and teambuilding for over 20 years. He has worked throughout the world with entrepreneurs and senior executives, 
												managers and individuals, privately and on behalf of other consulting organizations. He has created a unique approach 
												that integrates inner personal growth learning with outer behavioral skill development in an outdoor educational setting. 
												Bob has been involved in helping people with their professional and personal lives for two decades.
											</td></tr>
											<tr><td><b>Jagath Reddy Junutula (Board Chairman)</b></td><td><a href="https://www.linkedin.com/in/jagath/"><img src="resources/linkedIn_PNG38.png" width="40" height="40"></a></td></tr>
												<tr><td>Jagath Reddy Junutula holds a Ph.D. in Biochemistry and has over 20 yrs experience in life science research. He is 
												currently a Senior Vice President at ModMab Therapeutics. Prior to this role, he worked at Cellerant Therapeutics for over 4 years and Genentech for 13 years. Jagath 
												gained knowledge and experience in moving antibody-based therapeutic molecules from discovery phase to IND. He has 
												authored 60 peer-reviewed publications/patents and has presented his work at numerous international conferences. Jagath 
												has been working with EPPIC, a 15-year old non-profit organization that fosters entrepreneurial mentoring and promotes 
												partnering among life science professionals. He served as a President of EPPIC during 2010-2011 and is a board member since 2010.</td></tr>
											</tr>
											<tr><td><b>Ramesh Kamath</b></td><td><a href="#"><img src="resources/linkedIn_PNG38.png" width="40" height="40"></a></td></tr>
												<tr><td>Ramesh Kamath is a graduate electrical engineer and holds a masters in engineering management degree from the University of 
												Louisville. He is a registered professional engineer in Kentucky and California. Ramesh spent 15 yrs at Genentech (1994-2009) 
												and served in various senior management positions in engineering organization. Ramesh was responsible for Strategic Planning, 
												Project Engineering, Process Engineering Group, Automation Engineering Group and the Plant Support Technology Group. Ramesh is 
												also involved in various community and non-profit activities.
											</td></tr>
											<tr><td><b>Suryanarayana Sankuratri</b></td><td><a href="https://www.linkedin.com/in/thesurya/"><img src="resources/linkedIn_PNG38.png" width="40" height="40"></a></td></tr>
												<tr><td>Suryanarayana Sankuratri holds Ph.D. in Biochemistry over 25 yrs experience in the life science research in particular with 
												virology and infectious diseases. He is currently an Executive Director at Merck. Prior to this role, he worked at Roche 
												pharmaceuticals for over 18 years. Surya involved with many non-profit activities related professional career development 
												of life science scientists through IISc-AANA and other NGOs in India helping the local communities to understand preventive 
												approaches to overcome infectious diseases and improvement for better human health.</td></tr>
											</tr>
											<tr><td><b>Raji Pingali</b></td><td><a href="https://www.linkedin.com/in/lakshmi-pingali-7b131159/"><img src="resources/linkedIn_PNG38.png" width="40" height="40"></a></td></tr>
												<tr><td>Raji Pingali, Ph.D. in Chemistry, has been a Science educator for the past 25 years. With several years of teaching and tutoring 
												experience, she has spearheaded many community initiative programs for youth in STEM fields. Most notable are her contributions in 
												initiating Math Science Club, and Elementary Science Olympiad in the Bay Area, which have grown to encompass several school districts. 
												Under her able coaching, teams have won National Championship at the Middle School Science Bowl, and represented the State in Odyssey 
												of the Mind. Raji continues to champion many community causes in the STEM areas, while working as a Technical Engineer in the Software Industry.</td></tr>										
											</tr>											
											<tr><td><b>Nirmala Bandrapalli</b></td><td><a href="https://www.linkedin.com/in/nirmala-bandrapalli-pmp-73495ab/"><img src="resources/linkedIn_PNG38.png" width="40" height="40"></a></td></tr>
												<tr><td>Nirmala Bandrapalli holds a Masters degree in Biochemistry. Nirmala is a past President of Science Gurus and planning commissioner, 
												Burlingame City. She has been involved with SANG for about 10 years in various positions (including a Co-Chair). Nirmala is actively 
												working with Burlingame Community for Eductation (BCE), a non-profit organization that raises funds to support schools in Burlingame 
												school district. Nirmala worked as Auction Communication Manger of BCE for 2010-2011 term.</td></tr>
											</tr>
											<tr><td><b>Ram Mandalam</b></td><td><a href="https://www.linkedin.com/in/rammandalam/"><img src="resources/linkedIn_PNG38.png" width="40" height="40"></a></td></tr>
												<tr><td>Ram Mandalam, Ph.D., President & CEO of Cellerant Therapeutics, joined the company in 2005. Ram was previously Executive Director 
												of Product Development at Geron Corporation, where he managed the development and manufacturing of cell based therapies for treatment 
												of degenerative diseases and cancer. Prior to Geron, he was Director of Developmental Research at Aastrom Biosciences, where he was 
												responsible for the research and development programs involving ex vivo expansion of human bone marrow stem cells and dendritic cells. 
												Dr. Mandalam received his Ph.D. in Chemical Engineering from the University of Michigan. Dr. Mandalam is the author or co-author of several 
												publications,patent applications, and abstracts.</td></tr>
											</tr>
											<tr><td><b>Pradeep Fernandes</b></td><td><a href="https://www.linkedin.com/in/pradeep-fernandes-5474187/"><img src="resources/linkedIn_PNG38.png" width="40" height="40"></a></td></tr>
												<tr><td>Pradeep Fernandes is Co-founder and non-executive director of Cellworks Group. He has over twenty years of experience in semiconductor engineering 
												and life sciences. He has applied the engineering approaches and technologies to develop the mathematical solver engines and automation infrastructure 
												for the Cellworks proprietary technology for emulating disease physiology computationally. He holds a M.S. in Electrical Engineering and B.S. in Computer 
												Science. He is a prolific entrepreneur and also an angel investor in the technology space and sits on the boards of a few private companies and non-profit 
												organizations.</td></tr>
											</tr>
											<tr><td><b>Sita Bharathala</b></td><td><a href="https://www.linkedin.com/in/sitabharathala/"><img src="resources/linkedIn_PNG38.png" width="40" height="40"></a></td></tr>
												<tr><td> Sita Bharathala holds a B. Tech degree in Electrical Engineering and an M. Tech degree in Computer Science from Osmania University. She
												has over 30 years of experience in software engineering and quality assurance and is currently working as a Vice President of Quality and 
												Release Engineering at Veeva Systems, a cloud based solutions provider for the life sciences industry. Sita is also actively involved in various 
												community and non-profit activities.
												</td></tr>
											</tr>
											<tr><td><b>Viswanatham Katta</b></td><td><a href="https://www.linkedin.com/in/viswanatham-katta/"><img src="resources/linkedIn_PNG38.png" width="40" height="40"></a></td></tr>
												<tr><td>Viswanatham Katta holds PhD in chemistry from the University of Houston. He has a broad experience in therapeutic protein characterization 
												in general with an emphasis on mass spectrometry-based techniques of native/reduced/glycosylated/digested mAbs for information on integrity, 
												identity, modifications, variants and host-cell related impurities. He has worked in major biopharma companies both in the discovery research (Amgen) 
												and process development areas (Genentech and Medivation). He led a group of scientists in Protein Analytical Chemistry Department that contributed to 
												CMC sections for several INDs of biologics. Dr Katta has also led the analytical sub-team for Ocrelizumab from pre-clinical through phase 1 stage. 
												He has also successfully led the CMC team enabling first-in-human clinical trials of a thiomab-drug conjugate project. He currently provides consulting 
												to CMOs and early-stage biologics companies. 
												</td></tr>
											</tr>
										</table>
										
									</div>
								</div>
							</div>							
						</div>
					</div>

			<div id="right"></div>
		</div>		
			<div id="footer"></div>		
		</div>	
	</body>
</html>